WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeFundsValueAct Capital › Q4 2009

ValueAct Capital 13F holdings, Q4 2009

Holdings as of December 31, 2009 · filings on SEC EDGAR · latest filing →

ValueAct Capital disclosed 12 US equity positions worth $2.4bn in its Q4 2009 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 23.7% of the reported book, followed by SARA LEE CORP and IT. Against the Q3 2009 filing, it opened 3 new positions, added to 4 and reduced 1 among the top 12 holdings.

← Q3 2009 · Q1 2010 →

What did ValueAct Capital own in Q4 2009? Top 12 positions

#StockSectorWeightValueSharesΔ sharesvs Q3 2009
1 VALEANT PHARMACEUTICALS INTL 23.7%$565.1m17,775,903 0% held
2 SARA LEE CORP 17.9%$425.3m34,918,822 0% held
3 IT GARTNER GROUP INC NEW-CL A Technology 15.8%$375.1m20,790,013 0% held
4 C R BARD INC 8.6%$205.2m2,634,500 87% added
5 MDS INC 7.4%$176.8m23,107,700 0% held
6 BFH ALLIANCE DATA SYSTEM CORP Financial Services 7.0%$166.9m2,583,900 -23% reduced
7 WILLIS GROUP HOLDINGS LTD 6.6%$158.0m5,990,410 4% added
8 IMMUCOR INC 3.8%$90.2m4,457,779 20% added
9 VRSN VERISIGN INC Technology 3.7%$88.4m3,645,017 46% added
10 SNA SNAP ON TOOLS CORP Industrials 2.1%$49.9m1,180,609 new
11 WARNER CHILCOTT LIMITED 2.1%$49.2m1,726,848 new
12 OPLN KAR AUCTION SERVICES INC Consumer Cyclical 1.3%$31.1m2,258,828 new

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.